K. De Meer et al., In vivo research with stable isotopes in biochemistry, nutrition and clinical medicine: An overview, ISOT ENV H, 35(1-2), 1999, pp. 19-37
Tracers and kinetic modelling provide the opportunity to follow the movemen
t and to quantify the metabolic fates of biological compounds in vivo. For
studies in children and for repeated studies in adults, the use of stable i
sotopically labelled substrates are preferable and safe. Measurement of iso
topic enrichment in biological molecules is highly specific and can be extr
emely precise. This allows the development of models of biological system d
ynamics in cells and organs that are otherwise inaccessible for sampling. A
pplications in biochemistry, nutrition and clinical medicine show the poten
tial of stable isotopes in vivo. Methodology is of paramount importance and
includes the choice of bolus studies, (primed) continuous infusions, use o
f multiple tracers and use of isotopomer information and intrinsic labels.
There is no limit to the number and kind of compounds that can be traced. T
opics include intermediate metabolism (lipids, proteins and carbohydrates)
using hydrogen, carbon and nitrogen labels. In clinical medicine, C-13-brea
th tests are available for detection of Helicobacter pylori ([C-13]urea bre
ath test), and for assessment of a variety of gastro-intestinal and hepatic
functions (e.g. [C-13]octanoate and mixed [C-13]triglyceride breath tests
for studies of gastric emptying and fat absorption, respectively). Because
theoretical, methodological, physiological and practical aspects are intert
wined, in vivo research with stable isotopes demands close collaboration be
tween the clinical researcher and the chemist responsible for the mass spec
trometry.